We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
Researchers are developing inhalable mRNA-based medicines to reduce the need for injections. They have created a stable lipid-polymer nanoparticle that can effectively deliver mRNA to the lungs.
